Evidence map›Paper›PMID 41002558›Full record

ArticleCurrent oncology (Toronto, Ont.)2025

Correlation of

Chen Chen, Zijuan Hu, Min Ren, Longlong Bao, Ran Wei, Tian Tian, Xiaoli Zhu, Qianming Bai, Baohua Yu, Xiaoqiu Li and 1 more

Abstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. PIV, PNI and HALP score for predicting pathological complete response in breast cancer after neoadjuvant chemotherapy: a systematic review and meta-analysis.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Chen ChenDepartment of Pathology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Zijuan HuDepartment of Pathology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.ORCID 0000-0003-4770-6564
Min RenDepartment of Pathology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.ORCID 0000-0002-0019-5536
Longlong BaoDepartment of Pathology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Ran WeiDepartment of Pathology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Tian TianDepartment of Pathology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Xiaoli ZhuDepartment of Pathology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Qianming BaiDepartment of Pathology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Baohua YuDepartment of Pathology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Xiaoqiu LiDepartment of Pathology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Xiaoyan ZhouDepartment of Pathology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.

Funding

Innovation Group Project of Shanghai Municipal Health Commission No2019CXJQ031Innovation Program of Shanghai Science and Technology Committee No.20Z119003001Shanghai Municipal Key Clinical Specialty No.shslczdzk01301Shanghai Science and technology development fund No.19MC1911000
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Lymphoma, Large B-Cell, DiffuseTumor Suppressor Protein p53AdultAgedAged, 80 and overDNA Copy Number VariationsFemaleHumansImmunohistochemistryMaleMiddle AgedMutationPrognosisTP53 protein, humanTumor Suppressor Protein p53copy number variationdiffuse large B-cell lymphomanext-generation sequencingp53 immunohistochemistryprognostic markersTP53 mutations

Identifiers

PMID41002558
PMCPMC12468183

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.